Literature DB >> 27031642

Association between Types of Chronic Conditions and Cancer Stage at Diagnosis among Elderly Medicare Beneficiaries with Prostate Cancer.

Amit D Raval1,2, Suresh Madhavan2, Malcolm D Mattes3, Usha Sambamoorthi2.   

Abstract

The current retrospective observational study was conducted to examine the association between types of chronic conditions and cancer stage at diagnosis among elderly Medicare beneficiaries with prostate cancer using the Surveillance, Epidemiology, and End Results (SEER)-Medicare linked database. The study cohort consisted of elderly men (≥66 years) with prostate cancer diagnosed between 2002 and 2009 (N = 103,820). Cancer stage at diagnosis (localized versus advanced) was derived using the American Joint Committee on Cancer classification. Chronic conditions were identified during the year before cancer diagnosis and classified as: (1) only cardiometabolic (CM); (2) only mental health (MH); (3) only respiratory (RESP); (4) CM + MH; (5) CM + RESP; (6) MH + RESP; (7) CM+ MH + RESP; and (8) none of the 3 types of conditions. Chi-square tests and multivariable logistic regressions were used to test the unadjusted and adjusted associations between types of chronic conditions and cancer stage at diagnosis. The highest percentage (5.8%) of advanced prostate cancer was observed among elderly men with none of the 3 types of chronic conditions (CM, RESP, MH). In the adjusted logistic regression, those with none of the 3 types of chronic conditions were 44% more likely to be diagnosed with advanced prostate cancer compared to men with all the 3 types of chronic conditions. Elderly men without any of the selected chronic conditions were more likely to be diagnosed with advanced prostate cancer; therefore, strategies to reduce the risk of advanced prostate cancer should be targeted toward elderly men without these conditions.

Entities:  

Mesh:

Year:  2016        PMID: 27031642      PMCID: PMC5296923          DOI: 10.1089/pop.2015.0141

Source DB:  PubMed          Journal:  Popul Health Manag        ISSN: 1942-7891            Impact factor:   2.459


  30 in total

1.  Guideline for the management of clinically localized prostate cancer: 2007 update.

Authors:  Ian Thompson; James Brantley Thrasher; Gunnar Aus; Arthur L Burnett; Edith D Canby-Hagino; Michael S Cookson; Anthony V D'Amico; Roger R Dmochowski; David T Eton; Jeffrey D Forman; S Larry Goldenberg; Javier Hernandez; Celestia S Higano; Stephen R Kraus; Judd W Moul; Catherine M Tangen
Journal:  J Urol       Date:  2007-06       Impact factor: 7.450

2.  Diabetes mellitus, race and the odds of high grade prostate cancer in men treated with radiation therapy.

Authors:  Timur Mitin; Ming-Hui Chen; Yuanye Zhang; Brian J Moran; Daniel E Dosoretz; Michael J Katin; Michelle H Braccioforte; Sharon A Salenius; Anthony V D'Amico
Journal:  J Urol       Date:  2011-10-22       Impact factor: 7.450

3.  Revisiting the behavioral model and access to medical care: does it matter?

Authors:  R M Andersen
Journal:  J Health Soc Behav       Date:  1995-03

Review 4.  Diabetes mellitus and prostate cancer risk of different grade or stage: a systematic review and meta-analysis.

Authors:  Hua Xu; Hao-wen Jiang; Guan-xiong Ding; Hu Zhang; Li-min Zhang; Shan-hua Mao; Qiang Ding
Journal:  Diabetes Res Clin Pract       Date:  2013-01-05       Impact factor: 5.602

5.  Effect of age, tumor risk, and comorbidity on competing risks for survival in a U.S. population-based cohort of men with prostate cancer.

Authors:  Timothy J Daskivich; Kang-Hsien Fan; Tatsuki Koyama; Peter C Albertsen; Michael Goodman; Ann S Hamilton; Richard M Hoffman; Janet L Stanford; Antoinette M Stroup; Mark S Litwin; David F Penson
Journal:  Ann Intern Med       Date:  2013-05-21       Impact factor: 25.391

6.  Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer.

Authors:  Brenda K Edwards; Anne-Michelle Noone; Angela B Mariotto; Edgar P Simard; Francis P Boscoe; S Jane Henley; Ahmedin Jemal; Hyunsoon Cho; Robert N Anderson; Betsy A Kohler; Christie R Eheman; Elizabeth M Ward
Journal:  Cancer       Date:  2013-12-16       Impact factor: 6.860

7.  Comorbidities and the risk of late-stage prostate cancer.

Authors:  Steven T Fleming; Kathleen McDavid; Kevin Pearce; Dmitri Pavlov
Journal:  ScientificWorldJournal       Date:  2006-07-28

Review 8.  Effects of comorbidity on screening and early diagnosis of cancer in elderly people.

Authors:  Catherine Terret; Elisabeth Castel-Kremer; Gilles Albrand; Jean Pierre Droz
Journal:  Lancet Oncol       Date:  2009-01       Impact factor: 41.316

9.  Defining and measuring chronic conditions: imperatives for research, policy, program, and practice.

Authors:  Richard A Goodman; Samuel F Posner; Elbert S Huang; Anand K Parekh; Howard K Koh
Journal:  Prev Chronic Dis       Date:  2013-04-25       Impact factor: 2.830

10.  Chronic Condition Clusters and Polypharmacy among Adults.

Authors:  Ami Vyas; Xiaoyun Pan; Usha Sambamoorthi
Journal:  Int J Family Med       Date:  2012-08-01
View more
  2 in total

Review 1.  Comorbid chronic diseases and cancer diagnosis: disease-specific effects and underlying mechanisms.

Authors:  Cristina Renzi; Aradhna Kaushal; Jon Emery; Willie Hamilton; Richard D Neal; Bernard Rachet; Greg Rubin; Hardeep Singh; Fiona M Walter; Niek J de Wit; Georgios Lyratzopoulos
Journal:  Nat Rev Clin Oncol       Date:  2019-07-26       Impact factor: 66.675

Review 2.  Treating the patient and not just the cancer: therapeutic burden in prostate cancer.

Authors:  Daniel E Spratt; Neal Shore; Oliver Sartor; Dana Rathkopf; Kara Olivier
Journal:  Prostate Cancer Prostatic Dis       Date:  2021-02-18       Impact factor: 5.554

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.